Ignite Creation Date:
2024-05-05 @ 11:33 AM
Last Modification Date:
2024-10-26 @ 9:09 AM
Study NCT ID:
NCT00072150
Status:
COMPLETED
Last Update Posted:
2013-06-05
First Post:
2003-11-04
Brief Title:
Phase II Trial Of PS-341 Bortezomib In Patients With Previously Treated Advanced Urothelial Tract Transitional Cell Carcinoma
Sponsor:
National Cancer Institute NCI
Organization:
National Cancer Institute NCI
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Metastatic Transitional Cell Cancer of the Renal Pelvis and Ureter |
| Recurrent Bladder Cancer |
| Recurrent Transitional Cell Cancer of the Renal Pelvis and Ureter |
| Recurrent Urethral Cancer |
| Stage III Bladder Cancer |
| Stage III Urethral Cancer |
| Stage IV Bladder Cancer |
| Stage IV Urethral Cancer |
| Transitional Cell Carcinoma of the Bladder |
| Ureter Cancer |
Keywords: